Abstract:Chlamydia trachomatis may be an important cause of lower respiratory tract infection (LRTI) in infants born to mothers amongst whom there is a high prevalence of sexually transmitted disease. A study of 100 ambulatory infants with signs of LRTI in South Africa showed that 6% had C. trachomatis infection. The majority of the infected infants had received chloramphenicol eye ointment as prophylaxis. Half had previously visited a health facility for the same illness but the infection has been misdiagnosed. Infant… Show more
“…A study conducted in Alexandria and neighbouring rural areas in 2014 revealed the presence of C. pneumoniae in 31.4% of febrile children with respiratory infections using diagnostic real-time PCR [12] . Moreover, among 100 South African children with lower respiratory tract symptoms, 6% were reported to have C. trachomatis infections [13] .…”
Members of the Chlamydiales order are obligate intracellular pathogens causing acute and chronic infectious diseases. Chlamydiaceae are established agents of community- and zoonotically acquired respiratory tract infections, and emerging pathogens among the Chlamydia-related bacteria have been implicated in airway infections. The role of both in airway infections in Africa is underexplored. We performed a case -control study on the prevalence of Chlamydiaceae and Chlamydia-related emerging pathogens in children with febrile respiratory tract infections in West Africa, Ghana. Using a pan-Chlamydiales broad-range real-time PCR, we detected chlamydial DNA in 11 (1.9%) of 572 hospitalized febrile children with respiratory tract symptoms and in 24 (4.3%) of 560 asymptomatic age-matched controls (p 0.03). Chlamydiaceae were found to be common among both symptomatic and healthy Ghanaian children, with Chlamydia pneumoniae being the most prevalent species. Parachlamydiaceae were detected in two children without symptoms but not in the symptomatic group. We identified neither Chlamydia psittaci nor Simkania negevensis but a member of a new chlamydial family that shared 90.2% sequence identity with the 16S rRNA gene of the zoonotic pathogen Chlamydia pecorum. In addition, we found a new Chlamydia-related species that belonged to a novel family sharing 91.3% 16S rRNA sequence identity with Candidatus Syngnamydia venezia. The prevalence and spectrum of chlamydial species differed from previous results obtained from children of other geographic regions and our study indicates that both, Chlamydiaceae and Chlamydia-related bacteria, are not clearly linked to clinical symptoms in Ghanaian children.
“…A study conducted in Alexandria and neighbouring rural areas in 2014 revealed the presence of C. pneumoniae in 31.4% of febrile children with respiratory infections using diagnostic real-time PCR [12] . Moreover, among 100 South African children with lower respiratory tract symptoms, 6% were reported to have C. trachomatis infections [13] .…”
Members of the Chlamydiales order are obligate intracellular pathogens causing acute and chronic infectious diseases. Chlamydiaceae are established agents of community- and zoonotically acquired respiratory tract infections, and emerging pathogens among the Chlamydia-related bacteria have been implicated in airway infections. The role of both in airway infections in Africa is underexplored. We performed a case -control study on the prevalence of Chlamydiaceae and Chlamydia-related emerging pathogens in children with febrile respiratory tract infections in West Africa, Ghana. Using a pan-Chlamydiales broad-range real-time PCR, we detected chlamydial DNA in 11 (1.9%) of 572 hospitalized febrile children with respiratory tract symptoms and in 24 (4.3%) of 560 asymptomatic age-matched controls (p 0.03). Chlamydiaceae were found to be common among both symptomatic and healthy Ghanaian children, with Chlamydia pneumoniae being the most prevalent species. Parachlamydiaceae were detected in two children without symptoms but not in the symptomatic group. We identified neither Chlamydia psittaci nor Simkania negevensis but a member of a new chlamydial family that shared 90.2% sequence identity with the 16S rRNA gene of the zoonotic pathogen Chlamydia pecorum. In addition, we found a new Chlamydia-related species that belonged to a novel family sharing 91.3% 16S rRNA sequence identity with Candidatus Syngnamydia venezia. The prevalence and spectrum of chlamydial species differed from previous results obtained from children of other geographic regions and our study indicates that both, Chlamydiaceae and Chlamydia-related bacteria, are not clearly linked to clinical symptoms in Ghanaian children.
“…The "classical" presentation is the late onset type, which typically occurs around the sixth week of life. [33][34][35] The onset is an insidious development of nasal obstruction and/or discharge, tachypnea, and staccato cough, without fever or wheezing. Concomitant conjunctivitis is detected in half of the cases and serves as an important diagnostic clue to the diagnosis.…”
Section: Chlamydia Trachomatismentioning
confidence: 99%
“…Its etiological role in bronchopulmonary dysplasia in this group of patients has, however, not been ascertained yet. 35,36…”
Congenital pneumonia is one of the common causes of respiratory distress at birth, with significant morbidity and mortality in neonates, especially among preterm infants, and particularly in developing countries. The etiological agents are many and vary between the developed and underdeveloped parts of the world. Group B streptococci have been attributed as the most common organisms causing severe pneumonia, particularly in developed countries. Human immunodeficiency virus (HIV) is now an increasing risk in underdeveloped countries such as Zimbabwe. Ureaplasma spp. have been highlighted as an important cause of congenital pneumonia in recent years. Clinical manifestations are often nonspecified, and majority of infections appear within the first 48 hours of life. Establishing the microbial diagnosis of congenital pneumonia is challenging. Molecular diagnosis using polymerase chain reaction has an extremely improved diagnostic yield as compared with other conventional detection methods. However, it is often associated with a high level of contamination and may not be available in most hospitals. Management of congenital pneumonia is multifaceted and the most vital is towards eliminating the possible incriminating agent. This review updates the current knowledge on congenital pneumonia and discusses its etiology, diagnosis, preventive strategies, and management.
“…These may be the direct or indirect colonisation routes leading to the pharyngeal presence of C. trachomatis, which is the most frequent target site detected in about 70-77% of the infected neonates (Darville, 2005;Stenberg & Mårdh, 1990) and that serves as an infectious focus giving rise to recurrent conjunctivitis or pneumonia. Pharyngitis occasionally may persist up to 2 years of age or beyond (Bell et al, 1992;Mårdh, 2002;Rees et al, 1981, Zar et al, 1999. Fortunately, this type of colonisation remains often subclinical, as its progression to pneumonia is observed only in 30% of the cases (Chen et al, 2007).…”
Section: Respiratory Tract Infectionsmentioning
confidence: 99%
“…Severe congenital pneumonia due to C. trachomatis may even lead to fatal consequences in very preterm babies (25-32 weeks of gestation) (Attenburrow & Barker, 1986). Respiratory failure may affect primarily very preterm, low birth-weight infants, but there are documented cases of these also among near term babies or in untreated neonatal pneumonia (Herieka & Dhar, 2001, Zar et al, 1999. C. trachomatis infection has been associated with seriously chronic, occasionally lethal forms of pulmonary disorders of ventilated preterm neonates.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.